Stem Cell Therapy for Alzheimer's Disease: A Scoping Review for 2017-2022

Yunxiao Duan1, Linshuoshuo Lyu2, Siyan Zhan3,4

  • 1Department of Biostatistics, Yale School of Public Health, New Haven, CT 06510, USA.

Biomedicines
|January 21, 2023
PubMed

Insights

Stem cell therapy shows promise for Alzheimer's disease (AD) treatment, with four main types explored. Further research is needed to advance clinical applications for this neurodegenerative disorder.

Area of Science:

  • Neuroscience and Regenerative Medicine
  • Gerontology and Aging Research

Background:

  • Alzheimer's disease (AD) is a leading cause of mortality in the elderly, with limited effective treatments.
  • Current therapeutic options for AD are insufficient, necessitating novel treatment strategies.
  • Stem cell therapy presents a promising alternative to conventional drug therapies for AD.

Purpose of the Study:

  • To review the current applications of stem cell therapy in Alzheimer's disease research.
  • To explore the potential of different stem cell types for AD treatment.
  • To identify future research directions for optimizing stem cell-based therapies for AD.

Main Methods:

  • Review of studies utilizing four major stem cell types: neural stem cells, mesenchymal stem cells, embryonic stem cells, and induced pluripotent stem cells.
  • Analysis of stem cell applications at the cellular, animal model, and clinical levels for AD.
  • Synthesis of existing research to identify trends and gaps in stem cell therapy for AD.

Main Results:

  • All four major stem cell types have demonstrated potential applications in AD treatment.
  • Extensive research exists at the cellular and animal model levels, with fewer studies at the clinical level.
  • Stem cell therapy offers advantages over traditional drug therapies for managing AD.

Conclusions:

  • Stem cell therapy holds significant promise for the future treatment of Alzheimer's disease.
  • Increased research on diverse stem cell types and cross-disciplinary approaches is recommended.
  • Future advancements should focus on improving the timeliness and individualization of stem cell therapies for AD.

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
238
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
597
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.9K
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.3K